NIKKEI 225
27,781.02+497.43(+1.82%)HANG SENG
26,235.80+274.77(+1.06%)CRUDE OIL
71.18-2.77(-3.75%)GOLD FUTURES
1,818.80+1.60(+0.09%)DOW
34,935.67+0.20(+0.00%)BTC-GBP
28,577.68-1,201.40(-4.03%)
CytoDyn Inc. (CYDY)
| Previous close | 1.6900 |
| Open | 1.6300 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 1.4600 - 1.6400 |
| 52-week range | 1.3500 - 7.4000 |
| Volume | 3,507,385 |
| Avg. volume | 2,540,671 |
| Market cap | 949.956M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.2700 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
CytoDyn Announces That Director Nominations by Rosenbaum/Patterson Activist Group Are Invalid
VANCOUVER, Washington, August 02, 2021--CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a late-stage biotechnology company, announced today that the director nominations submitted by an activist group led by Paul Rosenbaum and Bruce Patterson (the "Rosenbaum/Patterson Group") were invalid. The Rosenbaum/Patterson Group attempted to nominate five director candidates to take over control of the Company’s six-member Board of Directors (the "Board").
- Business Wire
Group of Cytodyn Stockholders Nominates Five Highly Qualified Director Candidates to Replace Board Responsible for Mismanagement and Value Destruction
NEW YORK, July 01, 2021--A group of long-time stockholders (the "Nominating Stockholders") of CytoDyn Inc. ("CYDY or the "Company) (OTC: CYDY) today announced that it has sent a notice to CYDY nominating five highly experienced director candidates – Thomas Errico, MD, Bruce Patterson, MD, Paul Rosenbaum, Peter Staats, MD and Melissa Yaeger – to serve on the Company’s Board of Directors.
- Business Wire
CYTODYN 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against CytoDyn, Inc. - CYDY
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until May 17, 2021 to file lead plaintiff applications in securities class action lawsuits against CytoDyn, Inc. (OTC: CYDY), if they purchased the Company’s securities between March 27, 2020 through March 9, 2021, inclusive (the "Class Period"). These actions are pending in the United States District Court for the Western District of Washington.
